Skip to search.
 TSX Up 0.13% TSX Ventures Down 0.17%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
113.50 Up 3.71(3.38%) 4:00PM EST
|After Hours : 114.00 Up 0.50 (0.44%) 5:28PM EST - Nasdaq Real Time Price
Add to Portfolio
Prev Close:109.79
Open:111.05
Bid:112.44 x 1000
Ask:115.30 x 500
1y Target Est:118.95
Beta:1.14
Earnings Date:Apr 29 - May 4 (Est.)
Day's Range:111.05 - 116.70
52wk Range:55.04 - 116.70
Volume:2,777,967
Avg Vol (3m):1,265,580
Market Cap:18.06B
P/E (ttm):N/A
EPS (ttm):-0.92
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BMRNUp 3.38%18.06B
FOLDUp 2.85%826.56M
SHPGDown 0.66%46.57B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.26
Quarterly EPS Est (Mar-15) :-0.53
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.94

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback